These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24940637)

  • 21. The investigation of total PSA, free PSA, and free/total PSA ratio in patients with liver cirrhosis patients according to Child-Pugh score.
    Inci M; Rifaioglu MM; Inci M; Celik M; Demir M; Ulutas T; Davarci M; Motor VK; Davran R; Gokce C
    Urology; 2013 Mar; 81(3):617-22. PubMed ID: 23332995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of Free-PSA (fPSA) and fPSA/PSA-Ratio Using A Point-of-Care Device.
    Costa IAD; Hennenlotter J; Todenhöfer T; Neumann E; Deininger S; Aufderklamm S; Bedke J; Stenzl A; Rausch S
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes of serum total PSA and free PSA in patients with prostate carcinoma and benign prostate hyperplasia].
    Gao ZW; Liu G; Sheng BW
    Ai Zheng; 2004 Jun; 23(6):701-3. PubMed ID: 15191675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer.
    Carobene A; Guerra E; Locatelli M; Cucchiara V; Briganti A; Aarsand AK; Coşkun A; Díaz-Garzón J; Fernandez-Calle P; Røraas T; Sandberg S; Jonker N; Ceriotti F; ;
    Clin Chim Acta; 2018 Nov; 486():185-191. PubMed ID: 30063887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
    Ulmert D; Serio AM; O'Brien MF; Becker C; Eastham JA; Scardino PT; Björk T; Berglund G; Vickers AJ; Lilja H
    J Clin Oncol; 2008 Feb; 26(6):835-41. PubMed ID: 18281654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system.
    Cazanave Mora JM; Del Valle García R; Pérez López L; Bequer Ariza DC; Zulueta Rodríguez O; Melchor Rodríguez A; Hernández Pérez L; López Cisneros R; Arteaga Yera AL; Silva Cabrera E; Fernández Yero JL
    J Pharm Biomed Anal; 2022 Jan; 208():114470. PubMed ID: 34798395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Method comparison for determination of the tumor markers AFP, CEA, PSA and free PSA between Immulite 2000 XPI and Dimension Vista 1500.
    Zur B; Holdenrieder S; Walgenbach-Brünagel G; Albers E; Stoffel-Wagner B
    Clin Lab; 2012; 58(1-2):97-105. PubMed ID: 22372351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms.
    Filella X; Truan D; Alcover J; Quintó L; Molina R; Luque P; Coca F; Ballesta AM
    Urology; 2004 Jun; 63(6):1100-3; discussion 1103-4. PubMed ID: 15183958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophoretic subforms of free prostate-specific antigen in serum as promising diagnostic tool in prostate cancer diagnostics.
    Jung K; Hoesel W; Reiche J; Deger S; Kramer J; Loening SA; Lein M; Stephan C
    Urology; 2007 Feb; 69(2):320-5. PubMed ID: 17320672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural network.
    Stephan C; Cammann H; Deger S; Schrader M; Meyer HA; Miller K; Lein M; Jung K
    Urology; 2009 Oct; 74(4):873-7. PubMed ID: 19476981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of NIH-IV prostatitis on free and free-to-total PSA.
    Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
    Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Measurement and analysis of different serum PSA in patients with benign prostatic hyperplasia].
    Li Y; Xu P; Zhang PA; Su HW; Zhang J
    Zhonghua Nan Ke Xue; 2003 Aug; 9(5):361-3, 366. PubMed ID: 14513646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interassay Variability and Clinical Implications of Five Different Prostate-specific Antigen Assays.
    Kaufmann B; Pellegrino P; Zuluaga L; Ben-David R; Müntener M; Keller EX; Spanaus K; von Eckardstein A; Gorin MA; Poyet C
    Eur Urol Open Sci; 2024 May; 63():4-12. PubMed ID: 38558765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostatic and testicular parameters in lepromatous patients.
    Aglamis E; Tasdemir C; Yucel MO; Ceylan C; Erden I
    Lepr Rev; 2014 Mar; 85(1):48-53. PubMed ID: 24974442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison and analysis of two methods for serum free prostate-specific antigen (PSA) detection].
    Jiang YQ; Xie ZX; Liu Q; Liu TY; Ma ZR; Zhi HJ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):316-8. PubMed ID: 23189856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opium consumption is negatively associated with serum prostate-specific antigen (PSA), free PSA, and percentage of free PSA levels.
    Safarinejad MR; Asgari SA; Farshi A; Iravani S; Khoshdel A; Shekarchi B
    J Addict Med; 2013; 7(1):58-65. PubMed ID: 23296201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Derivatives of prostate-specific antigen as predictors of incidental prostate cancer.
    Froehner M; Buck LM; Koch R; Hakenberg OW; Wirth MP
    BJU Int; 2009 Jul; 104(1):25-8. PubMed ID: 19191782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardization of assay methods reduces variability of total PSA measurements: an Irish study.
    Forde JC; Marignol L; Blake O; McDermott T; Grainger R; Crowley VE; Lynch TH
    BJU Int; 2012 Sep; 110(5):644-50. PubMed ID: 22897326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate specific antigen ratio: for diagnosis and assessment of aggressiveness of malignancy of prostate.
    Kapoor N; Jain R; Surange S; Bhardwaj VK; Srivastava A
    Indian J Pathol Microbiol; 2006 Apr; 49(2):178-81. PubMed ID: 16933710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.